ArticleDiagnostics (Basel, Switzerland)2023
Exemplar MobileNetV2-Based Artificial Intelligence for Robust and Accurate Diagnosis of Multiple Sclerosis.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 22 citations in OpenAlex.
- Systematic review of unveiling the potential of AI using machine learning and deep learning methods in neurodegenerative diseases.PeerJ. Computer science · 2026Review
- From lesion detection to outcome prediction: artificial intelligence and deep learning applications in multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Applying machine learning with MobileNetV2 model for rapid screening of vaginal discharge samples in vaginitis diagnosis.Scientific reports · 2025Article
- Deep learning-based CAD system for Alzheimer's diagnosis using deep downsized KPLS.Scientific reports · 2025Article
- Article
- A Pyramid Deep Feature Extraction Model for the Automatic Classification of Upper Extremity Fractures.Diagnostics (Basel, Switzerland) · 2023Article
- Mapping neurodegeneration with diffusion MRI: biomarkers, mechanisms, and clinical translation.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that prominently affects young adults due to its debilitating nature. The pathogenesis of the disease is focused on the inflammation and neurodegeneration processes. Inflammation is associated with relapses, while neurodegeneration emerges in the progressive stages of the disease. Magnetic resonance imaging (MRI) is commonly used for the diagnosis of MS, and guidelines such as the McDonald criteria are available. MRI is an essential tool to demonstrate the spatial distribution and changes over time in the disease. This study discusses the use of image processing techniques for the diagnosis of MS and specifically combines the MobileNetV2 network with exemplar-based learning, IMrMr feature selection, and K-Nearest Neighbors (KNN) classification methods. Experiments conducted on two different datasets (Dataset 1 and Dataset 2) demonstrate that these methods provide high accuracy in diagnosing MS. Dataset 1 comprises 128 patients with 706 MRI images, 131 MS patients with 667 MRI images, and 150 healthy control subjects with 1373 MRI images. Dataset 2 includes an MS group with 650 MRI images and a healthy control group with 676 MRI images. The results of the study include 10-fold cross-validation results performed on different image sections (Axial, Sagittal, and Hybrid) for Dataset 1. Accuracy rates of 99.76% for Axial, 99.48% for Sagittal, and 98.02% for Hybrid sections were achieved. Furthermore, 100% accuracy was achieved on Dataset 2. In conclusion, this study demonstrates the effective use of powerful image processing methods such as the MobileNetV2 network and exemplar-based learning for the diagnosis of MS. These findings suggest that these methods can be further developed in future research and offer significant potential for clinical applications in the diagnosis and monitoring of MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.